Connection
James Crapo to Administration, Cutaneous
This is a "connection" page, showing publications James Crapo has written about Administration, Cutaneous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.193 |
|
|
|
-
Gad SC, Sullivan DW, Mujer CV, Spainhour CB, Crapo JD. Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis. Int J Toxicol. 2019 Jul/Aug; 38(4):291-302.
Score: 0.160
-
Stover K, Fukuyama T, Young AT, Daniele MA, Oberley R, Crapo JD, B?umer W. Topically applied manganese-porphyrins BMX-001 and BMX-010 display a significant anti-inflammatory response in a mouse model of allergic dermatitis. Arch Dermatol Res. 2016 Dec; 308(10):711-721.
Score: 0.033